Effects of hormonal contraception on bone mineral density after 24 months of use

Abbey Berenson, Carmen Radecki Breitkopf, James J. Grady, Vaughn I. Rickert, Angelyn Thomas

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

OBJECTIVE: To measure the effect of 24 months of depot medroxyprogesterone acetate use on bone mineral density compared with oral contraception (pills) and nonhormonal contraception. METHODS: Women aged 18-33 years self-selected oral contraception, depot medroxyprogesterone acetate, or nonhormonal contraception (controls). Those selecting pills were randomized to formulations containing either 35 μg ethinyl estradiol and norethindrone or 30 μg ethinyl estradiol and desogestrel. Controls were frequency matched on age and race/ethnicity to hormonal contraception users. Dual-energy X-ray absorptiometry of the lumbar spine (L1-L4) was performed at baseline, 12 months, and 24 months. Percent change in bone mineral density was analyzed by using analysis of covariance, adjusting for age, race/ethnicity, weight-bearing exercise, calcium intake, smoking status, and body mass index. RESULTS: Of the 191 women making up the final sample, 86 used pills, 47 used depot medroxyprogesterone acetate, and 58 used nonhormonal contraception. Women using depot medroxyprogesterone acetate for 24 months experienced, on average, a 5.7% loss in bone mineral density, with a 3.2% loss occurring between months 12 and 24. On average, users of desogestrel pills experienced a 2.6% loss in bone mineral density after 24 months. Bonferroni-adjusted pairwise comparisons demonstrated that bone mineral density changes from baseline to 24 months among depot medroxyprogesterone acetate users differed significantly from changes experienced by either of the pill groups or the control group. Changes in bone mineral density among users of either pill did not significantly differ from each other or from controls. CONCLUSION: Loss of bone mineral density associated with depot medroxyprogesterone acetate use appears to be linear during the first 2 years of use. Shifts in bone mineral density among pill users were not significant when compared with controls.

Original languageEnglish (US)
Pages (from-to)899-906
Number of pages8
JournalObstetrics and Gynecology
Volume103
Issue number5 I
DOIs
StatePublished - May 2004

Fingerprint

Contraception
Bone Density
Medroxyprogesterone Acetate
Desogestrel
Ethinyl Estradiol
Norethindrone
Photon Absorptiometry
Weight-Bearing
Spine
Body Mass Index
Smoking
Exercise
Calcium
Control Groups

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Effects of hormonal contraception on bone mineral density after 24 months of use. / Berenson, Abbey; Breitkopf, Carmen Radecki; Grady, James J.; Rickert, Vaughn I.; Thomas, Angelyn.

In: Obstetrics and Gynecology, Vol. 103, No. 5 I, 05.2004, p. 899-906.

Research output: Contribution to journalArticle

Berenson, Abbey ; Breitkopf, Carmen Radecki ; Grady, James J. ; Rickert, Vaughn I. ; Thomas, Angelyn. / Effects of hormonal contraception on bone mineral density after 24 months of use. In: Obstetrics and Gynecology. 2004 ; Vol. 103, No. 5 I. pp. 899-906.
@article{4ad3cef60a444760a4cdf3ae3b82154b,
title = "Effects of hormonal contraception on bone mineral density after 24 months of use",
abstract = "OBJECTIVE: To measure the effect of 24 months of depot medroxyprogesterone acetate use on bone mineral density compared with oral contraception (pills) and nonhormonal contraception. METHODS: Women aged 18-33 years self-selected oral contraception, depot medroxyprogesterone acetate, or nonhormonal contraception (controls). Those selecting pills were randomized to formulations containing either 35 μg ethinyl estradiol and norethindrone or 30 μg ethinyl estradiol and desogestrel. Controls were frequency matched on age and race/ethnicity to hormonal contraception users. Dual-energy X-ray absorptiometry of the lumbar spine (L1-L4) was performed at baseline, 12 months, and 24 months. Percent change in bone mineral density was analyzed by using analysis of covariance, adjusting for age, race/ethnicity, weight-bearing exercise, calcium intake, smoking status, and body mass index. RESULTS: Of the 191 women making up the final sample, 86 used pills, 47 used depot medroxyprogesterone acetate, and 58 used nonhormonal contraception. Women using depot medroxyprogesterone acetate for 24 months experienced, on average, a 5.7{\%} loss in bone mineral density, with a 3.2{\%} loss occurring between months 12 and 24. On average, users of desogestrel pills experienced a 2.6{\%} loss in bone mineral density after 24 months. Bonferroni-adjusted pairwise comparisons demonstrated that bone mineral density changes from baseline to 24 months among depot medroxyprogesterone acetate users differed significantly from changes experienced by either of the pill groups or the control group. Changes in bone mineral density among users of either pill did not significantly differ from each other or from controls. CONCLUSION: Loss of bone mineral density associated with depot medroxyprogesterone acetate use appears to be linear during the first 2 years of use. Shifts in bone mineral density among pill users were not significant when compared with controls.",
author = "Abbey Berenson and Breitkopf, {Carmen Radecki} and Grady, {James J.} and Rickert, {Vaughn I.} and Angelyn Thomas",
year = "2004",
month = "5",
doi = "10.1097/01.AOG.0000117082.49490.d5",
language = "English (US)",
volume = "103",
pages = "899--906",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "5 I",

}

TY - JOUR

T1 - Effects of hormonal contraception on bone mineral density after 24 months of use

AU - Berenson, Abbey

AU - Breitkopf, Carmen Radecki

AU - Grady, James J.

AU - Rickert, Vaughn I.

AU - Thomas, Angelyn

PY - 2004/5

Y1 - 2004/5

N2 - OBJECTIVE: To measure the effect of 24 months of depot medroxyprogesterone acetate use on bone mineral density compared with oral contraception (pills) and nonhormonal contraception. METHODS: Women aged 18-33 years self-selected oral contraception, depot medroxyprogesterone acetate, or nonhormonal contraception (controls). Those selecting pills were randomized to formulations containing either 35 μg ethinyl estradiol and norethindrone or 30 μg ethinyl estradiol and desogestrel. Controls were frequency matched on age and race/ethnicity to hormonal contraception users. Dual-energy X-ray absorptiometry of the lumbar spine (L1-L4) was performed at baseline, 12 months, and 24 months. Percent change in bone mineral density was analyzed by using analysis of covariance, adjusting for age, race/ethnicity, weight-bearing exercise, calcium intake, smoking status, and body mass index. RESULTS: Of the 191 women making up the final sample, 86 used pills, 47 used depot medroxyprogesterone acetate, and 58 used nonhormonal contraception. Women using depot medroxyprogesterone acetate for 24 months experienced, on average, a 5.7% loss in bone mineral density, with a 3.2% loss occurring between months 12 and 24. On average, users of desogestrel pills experienced a 2.6% loss in bone mineral density after 24 months. Bonferroni-adjusted pairwise comparisons demonstrated that bone mineral density changes from baseline to 24 months among depot medroxyprogesterone acetate users differed significantly from changes experienced by either of the pill groups or the control group. Changes in bone mineral density among users of either pill did not significantly differ from each other or from controls. CONCLUSION: Loss of bone mineral density associated with depot medroxyprogesterone acetate use appears to be linear during the first 2 years of use. Shifts in bone mineral density among pill users were not significant when compared with controls.

AB - OBJECTIVE: To measure the effect of 24 months of depot medroxyprogesterone acetate use on bone mineral density compared with oral contraception (pills) and nonhormonal contraception. METHODS: Women aged 18-33 years self-selected oral contraception, depot medroxyprogesterone acetate, or nonhormonal contraception (controls). Those selecting pills were randomized to formulations containing either 35 μg ethinyl estradiol and norethindrone or 30 μg ethinyl estradiol and desogestrel. Controls were frequency matched on age and race/ethnicity to hormonal contraception users. Dual-energy X-ray absorptiometry of the lumbar spine (L1-L4) was performed at baseline, 12 months, and 24 months. Percent change in bone mineral density was analyzed by using analysis of covariance, adjusting for age, race/ethnicity, weight-bearing exercise, calcium intake, smoking status, and body mass index. RESULTS: Of the 191 women making up the final sample, 86 used pills, 47 used depot medroxyprogesterone acetate, and 58 used nonhormonal contraception. Women using depot medroxyprogesterone acetate for 24 months experienced, on average, a 5.7% loss in bone mineral density, with a 3.2% loss occurring between months 12 and 24. On average, users of desogestrel pills experienced a 2.6% loss in bone mineral density after 24 months. Bonferroni-adjusted pairwise comparisons demonstrated that bone mineral density changes from baseline to 24 months among depot medroxyprogesterone acetate users differed significantly from changes experienced by either of the pill groups or the control group. Changes in bone mineral density among users of either pill did not significantly differ from each other or from controls. CONCLUSION: Loss of bone mineral density associated with depot medroxyprogesterone acetate use appears to be linear during the first 2 years of use. Shifts in bone mineral density among pill users were not significant when compared with controls.

UR - http://www.scopus.com/inward/record.url?scp=2942724262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942724262&partnerID=8YFLogxK

U2 - 10.1097/01.AOG.0000117082.49490.d5

DO - 10.1097/01.AOG.0000117082.49490.d5

M3 - Article

VL - 103

SP - 899

EP - 906

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 5 I

ER -